Significant increase in natural-killer T cells in patients with tuberculosis complicated by type 2 diabetes mellitus

Journal of International Medical Research

Volumn 39, Issue 1, 2011, Pages 105-111

  Zhang, Q ^a   Xiao, H P ^a   Cui, H Y ^a   Sugawara, I ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diabetes mellitus; Flow cytometry; NKT cells; Tuberculosis

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET RESTRICTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; LUNG LAVAGE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL;

EID: 79952920541     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900113     Document Type: Article

References (38)

1. Morton R: Phthisiologia. London: Smith and Welford, 1694.
2. Banyai AL: Diabetes and pulmonary tuberculosis. Am Rev Tuberc 1931; 24: 650-667.
3. Root HF: The association of diabetes and tuberculosis. N Engl J Med 1934; 210: 1-13.
4. Boucot K, Dillon E, Cooper D, et al: Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc 1952; 65(suppl 1): 1-50.
5. Sugawara I, Yamada H, Mizuno S: Pulmonary tuberculosis in spontaneously diabetic Goto Kakizaki rats. Tohoku J Exp Med 2004; 204: 135-145.
6. Sugawara I, Mizuno S: Higher susceptibility of type 1 diabetic rats to Mycobacterium tuberculosis infection. Tohoku J Exp Med 2008; 216: 363-370.
7. Al-Attiyah RJ, Mustafa AS: Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects. Clin Exp Immunol 2009; 158: 64-73.
8. Alisjahbana B, Van Crevel R, Sahiratmadja E, et al: Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006; 10: 696-700.
9. Tuberculosis Research Committee (Ryojen): Relapse rate of tuberculosis treated with standard regimen of chemotherapy. Kekkaku 2009; 84: 617-625 [in Japanese, English abstract].
10. Zhang Q, Xiao H, Sugawara I: Tuberculosis complicated by diabetes mellitus at Shanghai Pulmonary Hospital, China. Jpn J Infect Dis 2009; 62: 390-391.
11. Choi H-J, Xu H, Geng Y, et al: Bacterial infection alters the kinetics and function of iNKT cell responses. J Leukoc Biol 2008; 84: 1462-1471.
12. Fuss I, Heller F, Boirivant M, et al: Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 2004; 113: 1490-1497.
13. Mattner J, Debord K, Ismail N, et al: Exogenous and endogenous glycolipid antigen activated NKT cells during microbial infections. Nature 2005; 434: 525-529.
14. Yang Y, Ueno A, Bao M, et al: Control of NKT cell differentiation by tissue-specific micro-environments. J Immunol 2003; 171: 5913-5920.
15. Lee PT, Putnam A, Benlagha K, et al: Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 2002; 110: 793-800.
16. Snyder-Cappione JE, Nixon DF, Loo CP, et al: Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. J Infect Dis 2007; 195: 1361-1364.
17. Sugawara I, Yamada H, Mizuno S, et al: Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb) 2002; 82: 97-104.
18. World Health Organization (WHO): Definition, diagnosis and classification of diabetes mellitus and its complications. In: WHO Report No. WHO/NCD/NCS/99.2. Geneva: World Health Organization, 2002; pp 48-49.
19. Tsao TC, Chen CH, Hong JH, et al: Shifts of T4/T 8 T lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis. Chest 2002; 122: 1285-1291.
20. Kulpraneet M, Sukwit S, Sumransurp K, et al: Cytokine production in NK and NKT cells from Mycobacterium tuberculosis infected patients. Southeast Asian J Trop Med Public Health 2007; 38: 370-375.
21. Sutherland JS, Jeffries DJ, Donkor S, et al: High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting. Tuberculosis 2009; 89: 398-404.
22. Sada-Ovalle I, Chiba A, Gonzales A, et al: Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macro-phages, produce interferon-?, and kill intracellular bacteria. PLoS Pathog 2007; 4: e1000239.
23. Tupin E, Kinjo Y, Kronenberg M: The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 2007; 5: 405-417.
24. Apostolou I, Takahama Y, Belmant C, et al: Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA 1999; 96: 5141-5148.
25. Gansert JL, Kiessler V, Engele M, et al: Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 2003; 170: 3154-3161.
26. Al Majid FM, Abba AA: Immunophenotypic characterisation of peripheral T lymphocytes in pulmonary tuberculosis. J Postgrad Med 2008; 54: 7-11.
27. Sridhar CB, Kini U, Subhash K, et al: Comparative cytological study of lymph node tuberculosis in HIV-infected individuals and in patients with diabetes in a developing country. Diagn Cytopathol 2002; 26: 75-80.
28. Flynn JL, Chan J: Tuberculosis latency and reactivation. Infect Immun 2001; 69: 4195-4201.
29. Kadowaki N, Antonenko S, Ho S, et al: Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 2001; 193: 1221-1226.
30. Jadoon SM, Moin S, Ahmed TA, et al: Smear negative pulmonary tuberculosis and lymphocyte subsets. J Coll Physicians Surg Pak 2004; 14: 419-422.
31. Zahran WA, Ghonaim MM, Koura BA, et al: Human natural killer T cells, NK and T cells in pulmonary tuberculosis: potential indicators for disease activity and prognosis. Egypt J Immunol 2006; 13: 67-78.
32. Venkataswamy MM, Baena A, Goldberg MF, et al: Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guérin. J Immunol 2009; 183: 1644-1656.
33. Cohen NR, Garg S, Brenner MB: Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol 2009; 102: 1-94.
34. Chackerian A, Alt J, Perera V, et al: Activation of NKT cells protects mice from tuberculosis. Infect Immun 2002; 70: 6302-6309.
35. Maâlej S, Belhaoui N, Bourguiba M et al: Pulmonary tuberculosis and diabetes. A retrospective study of 60 patients in Tunisia. Presse Med 2009; 38: 20-24 [in French, English abstract].
36. Wang CS, Yang CJ, Chen HC, et al: Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 2009; 137: 203-210.
37. Griseri T, Beaudoin L, Novak J, et al: Invariant NKT cells exacerbate type 1 diabetes induced by CD 8 T cells. J Immunol 2005; 175: 2091-2101.
38. Restrepo BI, Fisher-Hoch SP, Pino PA, et al: Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 2008; 47: 634-641.